In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 10, 2000, Pages 2740-2746

  Nagai, K ^a   Davies, T A ^a   Pankuch, G A ^a   Dewasse, B E ^a   Jacobs, M R ^a   Appelbaum, P C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ASPARTIC ACID; CIPROFLOXACIN; CLINAFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); RESERPINE; SERINE; TROVAFLOXACIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROTYPING; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS, FLUOROQUINOLONE; BACTERIAL PROTEINS; CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASE IV; DNA TOPOISOMERASES, TYPE II; DNA-BINDING PROTEINS; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY TESTS; MUTATION; NAPHTHYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; SUPPORT, NON-U.S. GOV'T;

EID: 0033798091     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.10.2740-2746.2000     Document Type: Article

References (27)

1. Antimicrobial resistance in Streptococcus pneumoniae: An overview
2. Apparent involvement of a multidrug transporter in the fluoroquinolone resistance of Streptococcus pneumoniae
3. A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new 'respiratory quinolones'
4. Prevalence of putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae
5. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolone in Canada
6. Antipneumococal activities of gemifloxacin compared to those of nine other agents
7. In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae
8. Comparative activities of clinafloxacin against gram-positive and -negative bacteria
9. Primary targets of fluoroquinolones in Streptococcus pneumoniae
10. Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae
11. Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro
12. Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong
13. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. surveillance study
14. High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutation in parC and gyrA
15. Fluoroquinolone resistance in Streptococcus pneumoniae
16. Molecular epidemiology of Streptococcus pneumoniae with decreased susceptibility to penicillin in a Paris children's hospital
17. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: Role in fluoroquinolone resistance
18. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae
19. DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae
20. Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies
21. Antipneumococcal activity of grepafloxacin compared to that of other agents by time-kill methodology
22. In vitro selection of resistance to four β-lactams and azithromycin in Streptococcus pneumoniae
23. Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae
24. Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract
25. Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro
26. ParC and GyrA may be interchangeable initial targets of some fluoroquinolones in Streptococcus pneumoniae